scispace - formally typeset
J

Jason G. Cyster

Researcher at University of California, San Francisco

Publications -  214
Citations -  46949

Jason G. Cyster is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: B cell & Germinal center. The author has an hindex of 106, co-authored 199 publications receiving 42370 citations. Previous affiliations of Jason G. Cyster include London Research Institute & Howard Hughes Medical Institute.

Papers
More filters
Journal ArticleDOI

EBI2 Guides Serial Movements of Activated B Cells and Ligand Activity Is Detectable in Lymphoid and Nonlymphoid Tissues

TL;DR: A role for EBI2 is established in helping control B cell position at multiple stages during the Ab response and it is suggested that E BI2 responds to a broadly distributed lipid ligand.
Journal ArticleDOI

Association of T-Zone Reticular Networks and Conduits with Ectopic Lymphoid Tissues in Mice and Humans

TL;DR: TRCs and conduits are hallmarks of secondary lymphoid organs and of well-developed TLTs, in both mice and humans, and are likely to act as important scaffold and organizer cells of the T-cell–rich zone.
Journal ArticleDOI

A p38 MAPK-MEF2C pathway regulates B-cell proliferation

TL;DR: It is shown that MEF2C regulates proliferation in response to BCR stimulation via the p38 MAPK pathway, and p38 directly phosphorylates MEf2C via three residues in the C-terminal transactivation domain, establishing MEF 2C as a direct transcriptional effector of BCR signaling via p38MAPK.
Journal ArticleDOI

Phenotypic and Morphological Properties of Germinal Center Dark Zone Cxcl12-Expressing Reticular Cells.

TL;DR: These findings establish CRCs as a major stromal cell type in the GC DZ and suggest that CRCs support critical activities of GC B cells in the DZ niche through Cxcl12 expression and direct cell–cell interactions.
Journal ArticleDOI

The CDM protein DOCK2 in lymphocyte migration

TL;DR: The role of DOCK2 in lymphocyte homing to lymphoid tissues and recent findings for other CDM family molecules that provide a basis for understanding how Dock2 might function in lymphocytes are reviewed.